Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL

Alzheimer Disease and Associated Disorders

Volumn 20, Issue 1, 2006, Pages 49-55

  Jönsson, Linus ^a,f   Andreasen, Niels ^a   Kilander, Lena ^b   Soininen, Hilkka ^c   Waldemar, Gunhild ^d   Nygaard, Harald ^e   Winblad, Bengt ^a   Jönhagen, Maria Eriksdotter ^a   Hallikainen, Merja ^c   Wimo, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Mental Health Services CPH   (Denmark)

^e UNIVERSITY OF BERGEN   (Norway)

^f European Health Economics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; CLASSIFICATION; DAILY LIFE ACTIVITY; MENTAL HEALTH; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; STATISTICS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; STATISTICS;

EID: 33745657911     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000201851.52707.c9     Document Type: Article

References (28)

1. Hendersen AS, Jorm AF. Definition and epidemiology of dementia: a review. In: Sartorius N (ed). Dementia. John Wiley & Sons, Ltd.; Chichester: 2000.
2. von Strauss E, Viitanen M, De Ronchi D, et al. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol. 1999;56:587-592.
3. Lawton MP. Assessing quality of life in Alzheimer disease research. Alzheimer Dis Assoc Disord. 1997;11(Suppl 6):91-99.
4. Wimo A, Winblad B, Aguero-Torres H, et al. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord. 2003;17:63-67.
5. Samuels SC. Pharmacological treatment of dementia. In: Sartorius N (ed). Dementia. John Wiley & Sons, Ltd.; Chichester: 2000.
6. Karlsson G, Jönsson B, Wimo A, et al. Methodological issues in health economic studies of dementia. In: Winblad B (ed). The Health Economics of Dementia. John Wiley & Sons Ltd: Chichester; 1998.
7. Drummond B, O'Brien B, Stoddart G, et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd edn. Oxford, England: Oxford University Press: 1997.
8. Jönsson L. Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease. Pharmacoeconomics. 2003 (in press).
9. Feldman H, Gauthier S, Hecker J, et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001;57:613-620.
10. Wimo A, Winblad B, Stoffler A, et al. Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease. Pharmacoeconomics. 2003;21:327-340.
11. Johannesson M. Theory and Methods for Economic Evaluation of Health Care. Dordrecht; Kluwer Academic Publishers: 1996.
12. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
13. Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702-722.
14. Feeny D, Furlong WJ, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113-128.
15. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33:328-336.
16. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.
17. Folstein M, Folstein S, McHugh P. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res. 1975;12:189-198.
18. Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386-2391.
19. Kaufer DI, Cummings JL, Ketcher P, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233-239.
20. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
21. Logsdon R, Gibbons L, McCurry S, et al. Quality of life in Alzheimer's disease: patient and caregiver reports. J Mental Health & Ageing. 1999;5:21-32.
22. Bland M. An Introduction to Medical Statistics. Third edn. Oxford; Oxford University Press: 2000.
23. Neumann PJ, Sandberg EA, Araki SS, et al. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease. Med Decis Making. 2000;20:413-422.
24. Coucill W, Bryan S, Bentham P, et al. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care. 2001;39:760-771.
25. Tamim H, McCusker J, Dendukuri N. Proxy reporting of quality of life using the EQ-5D. Med Care. 2002;40:1186-1195.
26. Magaziner J, Simonsick EM, Kashner TM, et al. Patient-proxy response comparability on measures of patient health and functional status. J Clin Epidemiol. 1988;41:1065-1074.
27. Kiyak HA, Teri L, Borson S. Physical and functional health assessment in normal aging and in Alzheimer's disease: self-reports vs family reports. Gerontologist. 1994;34:324-330.
28. Ready RE, Ott BR, Grace J. Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19:256-265.